pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
i-mab-biopharma PRESS RELEASE ARCHIVE
Dec 13, 2021
I-MAB Biopharma and AGC Biologics Partner on Late-Phase Project
Jan 3, 2020
I-Mab Biopharma Announces Dosing of First Patient in a Pivotal Study of TJ202/MOR202 in Multiple Myeloma in Mainland China
Nov 14, 2019
I-Mab Biopharma Receives IND Approval from NMPA to Initiate Clinical Trials for its Anti-GM-CSF Monoclonal Antibody TJM2 in China
Oct 14, 2019
I-Mab Biopharma and MorphoSys Announce IND Clearance to Initiate Clinical Trials of TJ202/MOR202 for the Treatment of Multiple Myeloma in Mainland China
Oct 4, 2019
I-Mab Biopharma Receives IND Approval in China for Proprietary CD73 Antibody TJD5
Sep 23, 2019
I-Mab Biopharma Announces Clinical Collaboration to Evaluate TJC4 in Combination with KEYTRUDA (pembrolizumab) in Patients with Multiple Cancer Types
Sep 12, 2019
I-Mab Biopharma Expands Global Team, Appoints Neil K. Warma As General Manager of I-Mab U.S.
Sep 10, 2019
I-Mab Biopharma and Junshi Biosciences Announce Collaboration to Evaluate TJD5 in Combination with Toripalimab for the Treatment of Patients with Cancers in China
Apr 16, 2019
I-Mab Biopharma and WuXi Biologics Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs
Apr 10, 2019
I-Mab Biopharma Signs Agreement for Clinical Research of TJD5 in Combination Therapy
Apr 7, 2019
I-Mab Biopharma and Jiangsu Nhwa Pharmaceutical Announce Strategic Collaboration Agreement with Biodextris and a Boston-Based, Leading Academic Medical Center
Jul 30, 2018
ABL Bio and I-Mab Biopharma Announce Global Collaboration on Innovative Bispecific Antibodies
Jul 26, 2018
I-Mab Biopharma and ABL Bio Announce Global Collaboration on Innovative Bispecific Antibodies
